Using real-time qRT-PCR assay, we further validated that both adropin and Colgalt2 were significantly upregulated in the liver (Supplemental Figure 6), correlating with the reduction in steatosis and amelioration of NASH in MøFoxO1-KO mice. The gene discussed is COLGALT2; the disease is metabolic dysfunction-associated steatohepatitis.